These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 18775438)
1. Structural characteristics of alpha-synuclein oligomers stabilized by the flavonoid baicalein. Hong DP; Fink AL; Uversky VN J Mol Biol; 2008 Oct; 383(1):214-23. PubMed ID: 18775438 [TBL] [Abstract][Full Text] [Related]
2. Characterization of the non-fibrillar α-synuclein oligomers. Hong DP; Han S; Fink AL; Uversky VN Protein Pept Lett; 2011 Mar; 18(3):230-40. PubMed ID: 20858207 [TBL] [Abstract][Full Text] [Related]
3. Baicalein inhibits α-synuclein oligomer formation and prevents progression of α-synuclein accumulation in a rotenone mouse model of Parkinson's disease. Hu Q; Uversky VN; Huang M; Kang H; Xu F; Liu X; Lian L; Liang Q; Jiang H; Liu A; Zhang C; Pan-Montojo F; Zhu S Biochim Biophys Acta; 2016 Oct; 1862(10):1883-90. PubMed ID: 27425033 [TBL] [Abstract][Full Text] [Related]
4. Effect of 4-hydroxy-2-nonenal modification on alpha-synuclein aggregation. Qin Z; Hu D; Han S; Reaney SH; Di Monte DA; Fink AL J Biol Chem; 2007 Feb; 282(8):5862-70. PubMed ID: 17189262 [TBL] [Abstract][Full Text] [Related]
5. The flavonoid baicalein inhibits fibrillation of alpha-synuclein and disaggregates existing fibrils. Zhu M; Rajamani S; Kaylor J; Han S; Zhou F; Fink AL J Biol Chem; 2004 Jun; 279(26):26846-57. PubMed ID: 15096521 [TBL] [Abstract][Full Text] [Related]
6. Baicalein inhibits formation of α-synuclein oligomers within living cells and prevents Aβ peptide fibrillation and oligomerisation. Lu JH; Ardah MT; Durairajan SS; Liu LF; Xie LX; Fong WF; Hasan MY; Huang JD; El-Agnaf OM; Li M Chembiochem; 2011 Mar; 12(4):615-24. PubMed ID: 21271629 [TBL] [Abstract][Full Text] [Related]
7. Covalent α-synuclein dimers: chemico-physical and aggregation properties. Pivato M; De Franceschi G; Tosatto L; Frare E; Kumar D; Aioanei D; Brucale M; Tessari I; Bisaglia M; Samori B; de Laureto PP; Bubacco L PLoS One; 2012; 7(12):e50027. PubMed ID: 23272053 [TBL] [Abstract][Full Text] [Related]
8. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Conway KA; Harper JD; Lansbury PT Biochemistry; 2000 Mar; 39(10):2552-63. PubMed ID: 10704204 [TBL] [Abstract][Full Text] [Related]
9. Changes in secondary structure of α-synuclein during oligomerization induced by reactive aldehydes. Cai Y; Lendel C; Österlund L; Kasrayan A; Lannfelt L; Ingelsson M; Nikolajeff F; Karlsson M; Bergström J Biochem Biophys Res Commun; 2015 Aug; 464(1):336-41. PubMed ID: 26129771 [TBL] [Abstract][Full Text] [Related]
10. Structural Characterization of Individual α-Synuclein Oligomers Formed at Different Stages of Protein Aggregation by Atomic Force Microscopy-Infrared Spectroscopy. Zhou L; Kurouski D Anal Chem; 2020 May; 92(10):6806-6810. PubMed ID: 32347706 [TBL] [Abstract][Full Text] [Related]
11. High stability and cooperative unfolding of α-synuclein oligomers. Paslawski W; Andreasen M; Nielsen SB; Lorenzen N; Thomsen K; Kaspersen JD; Pedersen JS; Otzen DE Biochemistry; 2014 Oct; 53(39):6252-63. PubMed ID: 25216651 [TBL] [Abstract][Full Text] [Related]
12. Structural characteristics and membrane interactions of tandem α-synuclein oligomers. Dong C; Hoffmann M; Li X; Wang M; Garen CR; Petersen NO; Woodside MT Sci Rep; 2018 Apr; 8(1):6755. PubMed ID: 29712958 [TBL] [Abstract][Full Text] [Related]
13. Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein. Li J; Uversky VN; Fink AL Biochemistry; 2001 Sep; 40(38):11604-13. PubMed ID: 11560511 [TBL] [Abstract][Full Text] [Related]
14. Secondary structure of alpha-synuclein oligomers: characterization by raman and atomic force microscopy. Apetri MM; Maiti NC; Zagorski MG; Carey PR; Anderson VE J Mol Biol; 2006 Jan; 355(1):63-71. PubMed ID: 16303137 [TBL] [Abstract][Full Text] [Related]
15. Pressure effects on α-synuclein amyloid fibrils: An experimental investigation on their dissociation and reversible nature. Piccirilli F; Plotegher N; Spinozzi F; Bubacco L; Mariani P; Beltramini M; Tessari I; Militello V; Perucchi A; Amenitsch H; Baldassarri E; Steinhart M; Lupi S; Ortore MG Arch Biochem Biophys; 2017 Aug; 627():46-55. PubMed ID: 28624352 [TBL] [Abstract][Full Text] [Related]
16. Effects of nitration on the structure and aggregation of alpha-synuclein. Uversky VN; Yamin G; Munishkina LA; Karymov MA; Millett IS; Doniach S; Lyubchenko YL; Fink AL Brain Res Mol Brain Res; 2005 Mar; 134(1):84-102. PubMed ID: 15790533 [TBL] [Abstract][Full Text] [Related]
17. Defining α-synuclein species responsible for Parkinson's disease phenotypes in mice. Froula JM; Castellana-Cruz M; Anabtawi NM; Camino JD; Chen SW; Thrasher DR; Freire J; Yazdi AA; Fleming S; Dobson CM; Kumita JR; Cremades N; Volpicelli-Daley LA J Biol Chem; 2019 Jul; 294(27):10392-10406. PubMed ID: 31142553 [TBL] [Abstract][Full Text] [Related]
18. Mechanistic study of the inhibitory activity of Geum urbanum extract against α-Synuclein fibrillation. Lobbens ES; Breydo L; Skamris T; Vestergaard B; Jäger AK; Jorgensen L; Uversky V; van de Weert M Biochim Biophys Acta; 2016 Sep; 1864(9):1160-1169. PubMed ID: 27353564 [TBL] [Abstract][Full Text] [Related]
19. SDS-induced fibrillation of alpha-synuclein: an alternative fibrillation pathway. Giehm L; Oliveira CL; Christiansen G; Pedersen JS; Otzen DE J Mol Biol; 2010 Aug; 401(1):115-33. PubMed ID: 20540950 [TBL] [Abstract][Full Text] [Related]